Takara Bio Inc Sample Contracts
JOINT FILING AGREEMENTJoint Filing Agreement • December 27th, 2002 • Takara Bio Inc • Medicinal chemicals & botanical products
The undersigned parties hereby agree that the Schedule 13D filed herewith (and any amendments thereto) relating to the stock of Lynx Therapeutics, Inc. is being filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(f) under the Securities Exchange Act of 1934, as amended, on behalf of each such person.